Abstract
We have studied the effect of treatment with the adrenal steroids androst-5-ene-3β,17β-diol (Δ5-diol) and dehydroepiandrosterone (DHEA) on the growth and progesterone receptor levels of dimethylbenz-(a)anthracene (DMBA)-induced mammary tumors in the rat.
While the total number of tumors in ovariectomized animals was 0.60 ± 0.19 tumor per rat after 24 days, it increased to 2.54 ± 0.50 (p<0.01) and 1.42 ± 0.26 (p<0.01) in the Δ5-diol and DHEA (2 mg, twice daily) treated animals, respectively. While very few new tumors developed during a 24-day period in ovariectomized animals (0.07 ± 0.07/rat), an average of 0.47 ± 0.19 (p<0.05) new tumor per animal appeared in intact rats. In ovariectomized animals treated with Δ5-diol or DHEA, the numbers of new tumors were 0.77 ± 0.26 (p<0.05) and 0.42 ± 0.15 (p<0.05), respectively. An even more striking effect was observed on average total tumor area, which decreased from 4.70 ± 0.95 cm2 in intact animals to 0.75 ± 0.27 cm2 (p<0.01) following ovariectomy. Values of 9.79 ± 2.25 (p<0.01) and 3.93 ± 0.86 cm2 (p<0.01) were found in the Δ5-diol- and DHEA-treated ovariectomized animals, respectively.
Treatment of ovariectomized animals with Δ5-diol and DHEA caused a marked increase (p<0.01) in progesterone receptor levels in both the uteri and DMBA-induced mammary tumors. Uterine weight was also stimulated (p<0.01) by treatment with the two adrenal steroids.
The present data show that two adrenal C19-Δ5 steroids, Δ5-diol and DHEA, possess stimulatory effects analogous to those of estrogens on DMBA-induced mammary tumor growth and progesterone receptor levels in the rat, thus supporting the suggestion of an important role of these adrenal steroids in breast cancer and other estrogen-sensitive diseases in the human.
References
Huggins C, Grand LC, Brillantes FP: Mammary cancer induced by a single feeding of polynuclear hydrocarbons, and its suppression. Nature 189: 204–207, 1961
Asselin J, Kelly PA, Caron MG, Labrie F: Control of hormone receptor levels and growth of 7,12-dimethylbenz(a)anthracene-induced mammary tumors by estrogens, progesterone and prolactin. Endocrinology 101: 666–671, 1977
Asselin J, Labrie F: Effects of estradiol and prolactin on steroid receptor levels in 7,12-dimethylbenz(a)anthracene-induced mammary tumors and uterus in the rat. J Steroid Biochem 9: 1079–1082, 1977
Jones D, Cameron EHD, Griffiths K, Gleave EN, Forrest APM: Steroid metabolism by human breast tumours. Biochem J 116: 919–925, 1970
Miller WR, McDonald D, Forrest APM, Shivas AA: Metabolism of androgens by human breast tissue. Lancet i: 912, 1973
Griffiths K, Jones D, Cameron EHD, Gleave EN, Forrest APM: Transformation of steroids by mammary carcinoma tissue. In: Dao TL (ed): Estrogen Target Tissues and Neoplasia. University of Chicago Press, Chicago, 1972, pp 151–162
Adams JB, Li K: Biosynthesis of 17β-estradiol in human breast carcinoma tissue and a novel method for its characterization. Br J Cancer 31: 429–433, 1975
Van Doorn LG, Poortman J, Thijssen JHH, Schwartz F: Actions and interactions of 5-androstene-3β,17β-diol and estradiol-17β in the immature rat uterus. Endocrinology 108: 1587–1593, 1981
Seymour-Munn K, Adams J: Estrogenic effects of 5-androstene-3β,17β-diol at physiological concentrations and its possible implication in the etiology of breast cancer. Endocrinology 112: 486–491, 1983
Adams JB, Garcia M, Rochefort H: Estrogenic effects of physiological concentrations of 5-androstene-3β,17β-diol and its metabolism in MCF-7 human breast cancer cells. Cancer Res 41: 4720–4726, 1981
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265–275, 1951
Asselin J, Labrie F, Kelly PA, Philibert D, Raynaud JP: Specific progesterone receptors in dimethylbenz(a)-anthracene (DMBA)-induced mammary tumors. Steroids 27: 395–404, 1976
Asselin J, Mélançon R, Gourdeau Y, Labrie F, Bonne C, Raynaud JP: Specific binding of [3H]methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH). J Steroid Biochem 10: 483–486, 1979
Kramer CY: Extension of multiple range tests to group means with unequal numbers of replications. Biometrics 12: 307–310, 1956
Adams J: Control of secretion and the function of C19 Δ5-steroids of the human adrenal gland. Mol Cell Endocrinol 41: 1–17, 1985
Huggins C, Briziarelli G, Sutton Jr H: Rapid induction of mammary carcinoma in the rat and the influence of hormones on the tumors. J Expl Med 109: 25–41, 1959
Talwalker PK, Meites J, Mizuno H: Mammary tumor induction by estrogen or anterior pituitary hormones in ovariectomized rats given 7,12-dimethylbenz(a)anthracene. Proc Soc Exp Biol Med 116: 531–534, 1964
Leung BS, Sasaki GH, Leung JS: Estrogen-prolactin dependency in 7,12-dimethylbenz(a)anthracene-induced tumors. Cancer Res 35: 621–627, 1975
Poortman J, Vroegindewey-Jie D, Thijssen JHH, Schwarz F: Relative binding affinity of androstane and C-19-nor-androstane steroids for the estradiol receptor in human myometrial and mammary cancer tissue. Mol Cell Endocrinol 8: 27–34, 1977
Poulin R, Labrie F: Estrogenic effect of adrenal steroids in the human mammary carcinoma cell line ZR 75-1. In: Genazzani AR (ed): Frontiers in Gynecological Endocrinology. Parthenon, London, in press
Maroulis GB, Abraham GE: Ovarian and adrenal contribution to peripheral steroid levels in post-menopausal women. Obstet Gynecol 48: 150–154, 1976
Rosenfield RL, Otto P: Androstenediol levels in human peripheral plasma. J Clin Endocrinol Metab 35: 818–822, 1972
Bird CE, Morrow L, Fukumoto Y, Marcellus S, Clark AF: Δ5-androstenediol: kinetics of metabolism and binding to plasma proteins in normal men and women. J Clin Endocrinol Metab 43: 1317–1322, 1976
Bird CE, Murphy J, Boroomand K, Finnis W, Dressel D, Clark AF: Dehydroepiandrosterone: kinetics of metabolism in normal men and women. J Clin Endocrinol Metab 47: 818–822, 1978
Adams JB, Archibald L, Seymour-Munn K: Dehydro-epiandrosterone and androst-5-ene-3β,17β-diol in human mammary cancer cytosolic and nuclear compartments and their relationship to estrogen receptor. Cancer Res 40: 3815–3820, 1980
Bonney RC, Scanlon MJ, Reed MJ, Jones DL, Beranek PA, James VHT: Adrenal androgen concentrations in breast tumours and in normal breast tissue. The relationship to oestradiol metabolism. J Steroid Biochem 20: 501–504, 1984
van Landeghem AAJ, Poortman J, Nabuurs M, Thijssen JHH: Endogenous concentration and subcellular distribution of androgens in normal and malignant human breast tissue. Cancer Res 45: 2907–2912, 1985
Adams JB, Wong MSF: Paraendocrine behaviour of human breast carcinoma.In vitro transformation of steroids to physiologically active hormones. J Endocrinol 41: 41–52, 1968
Li K, Foo T, Adams JB: Products of dehydroepiandrosterone metabolism by human mammary tumors and their influence on estradiol receptor binding. Steroids 31: 113–127, 1978
Siiteri PK, McDonald DC: The role of extraglandular estrogens in human endocrinology. In: Geiger SR, Astwood EB, Greep RO (eds): Handbook of Physiology, Section 7. The American Physiology Society, New York, 1973, pp 615–619
Carlström K: Influence of intratumoral estradiol biosynthesis on estrogen receptors. In: Leclercq G, Toma S, Paridaens R, Heuson JC (eds): Recent Results in Cancer Research, Vol. 91. Springer-Verlag, Berlin, 1984, pp 145–149
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Spinola, P.G., Marchetti, B. & Labrie, F. Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors. Breast Cancer Res Tr 8, 241–248 (1986). https://doi.org/10.1007/BF01807337
Issue Date:
DOI: https://doi.org/10.1007/BF01807337